Stay updated with breaking news from Colleen Loo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Therapeutic Goods Administration (TGA) of Australia announced the groundbreaking decision in February, emphasizing that when used in controlled medical settings and in appropriate dosages, both drugs have shown relative safety.
Australia’s move to become the world’s first country to allow clinical prescribing of MDMA, and psilocybin for a spate of psychiatric conditions has left many clinicians and researchers concerned.
The use of synthetic drugs for therapeutic purposes, especially for treating mental health conditions, has been a topic for debate for some time now. Australia has become the first country in the world to legalise the use of psychedelics to treat certain mental health conditions
Australia is set to become the first country to legalize clinical prescribing of MDMA and psilocybin, the main psychoactive ingredient in magic mushrooms, for certain mental health disorders.
Authorised psychiatrists will be able to prescribe psychedelics to eligible patients as of July 1, but the path ahead is far from straightforward.